What We Do: NuVessl develops products to carry active ingredients in innovative and difficult conditions using our patented nanotechnology encapsulation platform. Nano-Lipidic Particle (NLP) Technology: NuVessl's patented NLP technology platform easily, cost-effectively and consistently manufactures 1 nm+ all-natural liposomes that accept single or multiple water-, fat- or bi-soluble AI. Competitive Advantages: ⁄ Deliver individual or different concurrent ingredients ⁄ Custom AI release: rapid, delayed, timed and/or sustained ⁄ Flavour masking or enhancing ⁄ Increased AI lifespan ⁄ Optically clear when AI-loaded ⁄ Dial-a-size custom NLP and assemblies of 1 nm+ ⁄ Inexpensive manufacturing & loading ⁄ Entirely natural, GRAS liposome components (GMO and organic possible) ⁄ Class-leading consistent 85%+ AI loading of liposomes Delivery: Interfaces - Skin, Oral, Nasal, Ocular, Intravenous, Intra-muscular, Pulmonary, Rectal, Ingested, Vaginal, Plant Surfaces Methods - Liquids, Drinks, Sprays, Creams, Pills, Gels, Powders, Emulsions, Lotions, Bandages Intellectual Property Status: Eight core patents protect the know-how related to the manufacture of NLP and encapsulation of AI. NuVessl has specific products or identified solutions in the following segments with over $300 Billion in potential segment sales: ⁄ Pharmaceuticals ⁄ Consumer Goods ⁄ Agriculture and Animal Health NuVessl achieves success through licensing, partnerships and proprietary brands.